ClinVar Miner

Submissions for variant NM_001127671.2(LIFR):c.756dup (p.Lys253Ter)

dbSNP: rs1745753552
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
CeGaT Center for Human Genetics Tuebingen RCV001091485 SCV001247559 pathogenic not provided 2019-11-01 criteria provided, single submitter clinical testing
Invitae RCV001091485 SCV001582994 pathogenic not provided 2023-04-09 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 871488). This premature translational stop signal has been observed in individuals with Stuve-Wiedemann syndrome (PMID: 14740318, 24477277, 25868946). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys253*) in the LIFR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LIFR are known to be pathogenic (PMID: 14740318).
Blueprint Genetics RCV001091485 SCV001832361 pathogenic not provided 2019-11-30 criteria provided, single submitter clinical testing
Centogene AG - the Rare Disease Company RCV001809981 SCV002059481 pathogenic Stuve-Wiedemann syndrome 2019-07-19 criteria provided, single submitter clinical testing
Institute of Human Genetics, Clinical Exome/Genome Diagnostics Group, University Hospital Bonn RCV001809981 SCV002103032 pathogenic Stuve-Wiedemann syndrome 2021-02-10 criteria provided, single submitter clinical testing PVS1, PS4_moderate, PM2
Laboratory of Medical Genetics, National & Kapodistrian University of Athens RCV002286811 SCV002577579 pathogenic Stüve-Wiedemann syndrome 1 2022-03-02 criteria provided, single submitter clinical testing PVS1, PM2, PP5
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München RCV002286811 SCV002764775 pathogenic Stüve-Wiedemann syndrome 1 2022-06-21 criteria provided, single submitter clinical testing
GeneDx RCV001091485 SCV003837468 pathogenic not provided 2023-03-03 criteria provided, single submitter clinical testing Nonsense variant predicted to result in protein truncation or nonsense-mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24477277, 19371797, 25868946, 34958143, 33305909, 14740318)
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001809981 SCV003922864 pathogenic Stuve-Wiedemann syndrome 2023-03-17 criteria provided, single submitter clinical testing Variant summary: LIFR c.756dupT (p.Lys253X), also referred to as c.756_757insT, results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 250744 control chromosomes (gnomAD). c.756dupT has been reported in the literature in multiple homozygous individuals affected with Stuve-Wiedemann Syndrome (e.g. Dangoneau_2004, Corona-Rivera_2009, Buonuomo_2014). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Eight submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.